Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

UROVANT

  • FDA Approval
  • Oct. 09, 2024, 17:05 UTC
  • 23
  • 0 comments

FDA approve VIBEGRON

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 09, 2024, 08:43 UTC
  • 20
  • 0 comments

FDA approve ESCITALOPRAM OXALATE

Comment Full text

SAPTALIS PHARMS

  • FDA Approval
  • Oct. 09, 2024, 08:43 UTC
  • 26
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • Oct. 09, 2024, 08:43 UTC
  • 20
  • 0 comments

FDA approve IOHEXOL

Comment Full text

SPECGX LLC

  • FDA Approval
  • Oct. 09, 2024, 08:43 UTC
  • 22
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Oct. 09, 2024, 08:43 UTC
  • 25
  • 0 comments

FDA approve ESCITALOPRAM OXALATE

Comment Full text

AMNEAL PHARMS NY

  • FDA Approval
  • Oct. 07, 2024, 17:07 UTC
  • 28
  • 0 comments

FDA approve PYRIDOSTIGMINE BROMIDE

Comment Full text

APOPHARMA A DIV OF APOTEX INC

  • FDA Approval
  • Oct. 07, 2024, 16:52 UTC
  • 29
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

PRINSTON PHARMA INC

  • FDA Approval
  • Oct. 07, 2024, 13:33 UTC
  • 28
  • 0 comments

FDA approve SITAGLIPTIN

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • Oct. 07, 2024, 13:02 UTC
  • 26
  • 0 comments

FDA approve SUGAMMADEX

Comment Full text
  • Previous
  • 242
  • 243
  • 244
  • 245
  • 246
  • Next

Search

News categories

  • Technical Exchange News(9928)
  • Event(412)
  • SEC News(168150)
  • FDA Approval(9362)
  • Company Report(721)
  • Business News(111930)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin